Tag Archives: Immunotherapy

A Poignant Election Day Comeback

Rep. DeSaulnier (center) with representatives of the American Cancer Society

On Election Day, a day of underdogs and upsets in American politics, Representative Mark DeSaulnier may have scored the greatest comeback of them all. Six months after completing chemotherapy to treat chronic lymphocytic leukemia, he has now beaten cancer and his opponent for California’s 11th district congressional seat. The type of leukemia that was diagnosed in Rep. DeSaulnier is the most common form of blood cancer in adults. Once it goes into remission, the five-year Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

ICYMI: NYT Chronicles Advances in Cancer Landscape Due to Immunotherapy

health care, medicine

This week, the New York Times published a series of articles titled Cell Wars which explores the novel uses of immunotherapy to combat cancer. Patient stories were shared where immunotherapy cured them of lung, prostate, liver, and brain cancer. Included were stories of researchers who have dedicated their lives to finding new treatments and cures. As the article states, there is a new era of optimism — a sense that they have begun tapping into a force of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Power of Innovation

Breast Cancer

Today’s “Fox and Friends” included an informative segment about the staggering advances being made in cancer care thanks to new and forthcoming innovative treatments. The segment featured five doctors from the Sarah Cannon Research Institute, a Nashville-based research organization that partners with biopharmaceutical companies to offer more than 500 clinical trials annually. “Over 40 years since President Nixon declared the War on Cancer, and after decades of giving more drugs and more radiation, we’re now Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming the body’s own t-cells to have greater impact on reducing tumors and preventing the spread of disease. CAR-T methods that extract, reengineer, and reintroduce a given patient’s t-cells provide highly personalized therapy but may be difficult to scale up. The interleukin enhancement approach motivates existing t-cells to be more effective and may be easier to deliver but have less pervasive Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,